The longevity industry can make impressive claims: biological-age clocks, supplement stacks, continuous glucose monitors, peptide protocols and ever more sophisticated ways of measuring how old (or how young) we supposedly are.
But step back from the marketing, and it is important to analyze the scientific evidence.
Some interventions have demonstrated reductions in mortality in randomized trials. Others have very strong observational evidence but cannot establish causality with the same confidence. And some are clearly valuable for preventing specific diseases without having been proven to extend overall lifespan.
That distinction matters.
Here is what currently stands on the firmest scientific ground.
Tier 1 — Strongest evidence for reducing mortality or major clinical events
1. Don't smoke, or stop as early as possible
Few interventions have a larger effect on longevity. A Cochrane meta-analysis of 68 studies and 80,702 participants found that quitting smoking reduced the risk of cardiovascular disease by about a third, and improved quality of life, in people with coronary heart disease[1].
The British Doctors Study followed 34,439 male physicians for 50 years. Lifelong cigarette smokers born between 1900 and 1930 died, on average, about 10 years earlier than lifelong nonsmokers. Stopping at about 30 years old avoided almost all of the excess mortality; stopping at 40, 50 or 60 progressively reduced the loss of life expectancy[2].
Smoking cessation is therefore not a "healthy lifestyle choice" in the vague sense of the phrase. It is one of the most powerful interventions available for changing an individual's long-term mortality risk.
2. Blood pressure control: detect and appropriately treat hypertension
High blood pressure is one of the most important modifiable causes of cardiovascular disease, stroke and premature death. Blood pressure lowering has the broadest and most consistent evidence base for preventing major cardiovascular events and death. Across 123 trials with 613,815 participants, each 10 mm Hg reduction in systolic pressure lowered major cardiovascular events by 20%, stroke by 27%, heart failure by 28%, coronary heart disease by 17% and all-cause mortality by 13%[3]. Large individual-participant analyses since then have confirmed the benefit across different starting blood pressures, and in people with and without type 2 diabetes[4][5].
In SPRINT, 9,361 adults at increased cardiovascular risk were randomized to an intensive systolic blood-pressure target of below 120 mm Hg or a standard target below 140 mm Hg. The trial was stopped early because intensive treatment produced significantly fewer major cardiovascular events and lower all-cause mortality[6].
This does not mean that every person should independently attempt to achieve a systolic pressure below 120 mm Hg. The appropriate target depends on the individual, measurement method, age, comorbidities and treatment risks.
The take-home message is simple: know your blood pressure and treat hypertension appropriately.
3. Treat cardiovascular risk when indicated, including LDL cholesterol
Lowering LDL cholesterol with statins reduces cardiovascular events, and randomized-trial evidence supports their use in appropriately selected patients at elevated cardiovascular risk.
Statins and LDL lowering reduce all-cause mortality and major vascular events in both primary and secondary prevention, with about a 21% reduction in major vascular events for every 1 mmol/L reduction in LDL cholesterol[7][8][9].
A meta-analysis of 11 randomized trials involving 65,229 high-risk primary-prevention participants found that statin therapy was associated with lower all-cause mortality[10]. More recent systematic reviews have incorporated substantially larger randomized evidence bases and continue to support statins for appropriately selected primary-prevention populations[7].
This is an important distinction: a high LDL value is not itself a disease that everyone must treat with medication. The decision to start a statin depends on absolute cardiovascular risk, age, LDL level, comorbidities and patient preferences.
The preventive principle is therefore not "everyone with a high LDL value should take a statin." It is to identify cardiovascular risk early and treat it when the expected benefit outweighs the harms.
4. Participate in appropriate cancer screening
Cancer screening is different from a longevity supplement: its benefit comes from detecting disease earlier, when treatment is more likely to be successful, and in some cases from preventing cancer altogether.
Colorectal cancer screening is one of the clearest examples. Randomized trials of fecal occult blood testing have demonstrated reductions in colorectal-cancer mortality[11].
The key word is appropriate. Screening recommendations depend on age, sex, family history, genetic risk and the particular cancer being considered. More screening is not automatically better.
Tier 2 — Strong evidence of association, with biological plausibility but less direct causal proof
5. Build and maintain cardiorespiratory fitness
If there is a single physical characteristic that repeatedly predicts longevity, it is fitness.
In a cohort of 122,007 adults undergoing treadmill testing, mortality decreased progressively as cardiorespiratory fitness increased. The highest fitness category had substantially lower adjusted mortality than the lowest, and the investigators observed no clear upper threshold at which the association disappeared[12].
The study was observational, so it cannot prove that increasing fitness by itself will produce exactly the same reduction in mortality. Nevertheless, the consistency of the association across populations, together with extensive experimental evidence showing benefits of exercise on cardiovascular and metabolic health, makes physical fitness one of the most compelling targets in preventive medicine.
6. Move more, and sit less
The message is consistent across large populations: more physical activity is associated with lower premature mortality.
A harmonized meta-analysis using accelerometer data from more than 36,000 adults found a strong inverse relationship between physical activity and all-cause mortality. Even relatively modest increases in activity were associated with substantially lower risk among the least active participants[13].
Importantly, this does not require becoming an elite athlete. Walking, cycling, recreational activity, resistance training and other forms of movement all contribute.
The most useful advice may be the simplest: move regularly, build fitness, and break up prolonged sitting.
7. Dietary restructuring: a Mediterranean-style diet
Evidence from meta-analysis suggests that Mediterranean dietary programs (high in vegetables, fruits, extra-virgin olive oil, nuts, legumes and fish) were superior to minimal interventions for reducing the risk of cardiovascular mortality, stroke and myocardial infarction over five years, in patients with obesity, hypertension, dyslipidemia or a previous cardiovascular event. Randomized trials that provided the food itself (for example extra-virgin olive oil, or mixed nuts, primarily walnuts) to people living in Mediterranean regions showed the largest effects. Similarly, moderate-certainty evidence showed that low-fat dietary programs (for example 20–30% total fat and under 10% saturated fat, high in fish, vegetables and fruit, together with varying co-interventions) were superior to minimal intervention for reducing all-cause mortality[14].
The approach is not a single "superfood" but an overall dietary pattern rich in vegetables, fruits, legumes, whole grains, nuts, olive oil and fish, with relatively little highly processed food and processed meat.
In PREDIMED, a randomized trial of people at elevated cardiovascular risk, Mediterranean diets supplemented with extra-virgin olive oil or nuts reduced major cardiovascular events compared with a control diet[15].
The strongest evidence is for cardiovascular disease prevention, rather than a definitive demonstration that the diet adds a specific number of years to everyone's life.
8. Prevent or delay type 2 diabetes
Type 2 diabetes substantially increases the risk of cardiovascular disease, kidney disease, neuropathy and other complications.
The Diabetes Prevention Program demonstrated that intensive lifestyle intervention can substantially reduce progression from impaired glucose tolerance to diabetes. Long-term follow-up has confirmed persistent benefits for diabetes prevention[16].
For longevity, the important principle is broader than "avoid diabetes": maintain metabolic health over decades.
That means addressing excess adiposity when present, maintaining physical activity, preserving muscle mass and monitoring glycemia when risk is elevated.
9. Sleep enough, and investigate persistent sleep problems
Sleep is increasingly recognized as a component of preventive health, although the evidence is not as strong as that for smoking, blood pressure or exercise.
Large prospective studies and meta-analyses consistently find associations between unusually short or long sleep duration and increased mortality[17][18].
But this is an area where causality is difficult to disentangle. Poor health can cause poor sleep, making the relationship bidirectional.
The practical conclusion is therefore modest but useful: regularly getting sufficient, good-quality sleep matters, and persistent insomnia, excessive daytime sleepiness or suspected sleep apnea deserve medical attention.
10. Preserve muscle strength as you age
Longevity is not simply about avoiding death. It is also about preserving the capacity to live independently.
Sarcopenia, the age-related decline in muscle mass and function, is associated with frailty, falls, disability and mortality. A meta-analysis across different clinical conditions found a significant association between sarcopenia and mortality[19].
The causal question remains less settled than it is for smoking or blood-pressure treatment. Nevertheless, maintaining muscle through resistance exercise, adequate nutrition and regular physical activity is one of the most rational strategies for preserving physical function with age.
Tier 3 — Important preventive measures with disease-specific or predominantly observational longevity evidence
11. Keep alcohol consumption low
Alcohol is a good example of how recommendations change. Historically, observational studies suggested that moderate alcohol consumption might benefit cardiovascular health. More recent analyses have concluded that even small amounts of alcohol cause harm. Epidemiological and toxicological evidence confirms that ethanol is a Group 1 carcinogen: according to the International Agency for Research on Cancer (IARC), alcohol is causally responsible for gastrointestinal and breast cancers[20][21][22].
The links observed between light red-wine consumption and longevity stem primarily from lifestyle confounding, such as adherence to the broader Mediterranean diet, rather than from any proven life extension by compounds in red wine[23][24][25].
12. Maintain a healthy body composition, focusing on metabolic and functional health rather than a number on the scale
Excess adiposity is associated with increased risk of cardiovascular disease, type 2 diabetes, several cancers and other chronic conditions.
However, simplistic longevity marketing often turns body weight into a single target. BMI does not distinguish muscle from fat, nor does it capture visceral adiposity, fitness or metabolic health.
A better preventive approach is to consider the whole picture: waist circumference, metabolic health, physical fitness, muscle mass, diet and long-term weight trajectory.
13. Vaccination remains one of the oldest forms of preventive medicine
Vaccination is rarely marketed as "longevity medicine," but preventing serious infectious disease is fundamentally a longevity intervention.
The appropriate vaccines depend on age, medical conditions, occupation, travel and epidemiological risk. For older adults, influenza, pneumococcal, shingles and other recommended vaccines can reduce the burden of serious infectious disease.
Importantly, the evidence for mortality reduction varies by vaccine and population; observational vaccine studies can be affected by healthy-user bias.
14. Reduce exposure to major environmental risks
Air pollution is not something an individual can always control, but it belongs in a serious discussion of preventive health.
Long-term exposure to fine particulate matter (PM2.5) is consistently associated with cardiovascular and respiratory disease and premature mortality in large cohort studies.
This does not mean that every individual needs an air purifier or must move to the countryside. It means that environmental exposures belong in the broader picture of lifetime risk, particularly for people with cardiopulmonary disease.
The hierarchy matters
Not every intervention marketed under the banner of "longevity" carries the same weight. Some are strongly supported by evidence; for others, the evidence is moderate or even weak.
At one end are interventions such as smoking cessation and appropriate treatment of cardiovascular risk, where the evidence for preventing premature death is exceptionally strong.
In the middle are interventions such as physical activity, cardiorespiratory fitness, diet and muscle preservation, where the evidence is extensive and biologically coherent but where much of the direct longevity evidence comes from observational studies.
Further down the hierarchy are interventions for which the evidence is promising but considerably less certain.
That distinction does not make the weaker evidence useless. It simply means we should not confuse association with causation, or a reduction in disease-specific mortality with proof of longer overall lifespan.
The unglamorous longevity prescription
After stripping away the noise, the core prescription is familiar:
- 1.Don't smoke.
- 2.Know your blood pressure.
- 3.Manage cardiovascular risk.
- 4.Stay physically active.
- 5.Build and preserve muscle.
- 6.Eat a predominantly minimally processed, Mediterranean-style diet.
- 7.Maintain metabolic health.
- 8.Sleep adequately.
- 9.Drink little or not at all.
- 10.Use evidence-based cancer screening.
- 11.Keep vaccinations up to date.
- 12.Address major environmental and medical risk factors early.
None of this is particularly futuristic, and that is the most important point: the interventions with the strongest evidence for a longer, healthier life were largely established before longevity became an industry. We will take each of these points in turn in the pieces that follow.
The next generation of medicine may eventually give us genuinely transformative tools for slowing biological aging. But until those interventions demonstrate meaningful improvements in human clinical outcomes, the foundation of longevity medicine remains surprisingly conventional: prevent disease, detect it early, treat major risk factors aggressively when appropriate, and preserve physical function for as long as possible.